SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " UNO " 789 found 🔀 AI-powered Shuffle
Trump gets the complete domination he wanted in Louisiana
Rep. Julia Letlow, his preferred candidate, won the GOP runoff for his longtime rival Bill Cassidy’s Senate seat.
Julia Letlow defeats John Fleming in GOP Senate runoff. Jamie Davis wins Democratic nod.
Letlow staved off a tough challenge from Treasurer John Fleming, while Davis overwhelmingly one his party’s nomination.
Trump-backed Rep. Julia Letlow wins Louisiana Senate primary runoff
Letlow defeated state Treasurer John Fleming in the GOP runoff, NBC News projects. Incumbent Sen. Bill Cassidy did not make the runoff.
Trump-backed Julia Letlow faces John Fleming in Louisiana GOP Senate runoff
U.S. Rep. Julia Letlow, who was endorsed by Trump, and state Treasurer John Fleming are competing in the runoff. The two finished ahead of Sen. Bill Cassidy in the May 16 primary after Trump denounced the two-term senator, who voted to convict him following his 2021 impeachment.
After ousting Bill Cassidy, Donald Trump faces fresh test of his sway with GOP voters in Louisiana’s Senate runoff
Louisiana Republican voters already rejected an incumbent senator who was crossways with President Donald Trump. In a primary runoff on Saturday, they’ll decide whether to follow Trump’s lead in choosing a new nominee.
Letlow, Fleming face off for Cassidy's seat in Louisiana GOP Senate runoff
Trump-backed Letlow faces Fleming in Louisiana GOP Senate runoff
President Donald Trump’s choice for U.S. Senate in Louisiana is seeking to secure the GOP nomination and deliver another win for the president in his effort to replace Republicans who crossed him
Live Results: Louisiana midterm primary runoffs
Louisiana Republicans will nominate a candidate for U.S. Senate in a primary runoff Saturday, six weeks after denying Republican U.S. Sen. Bill Cassidy a shot at a third term.
The Science Of Speed: How Mizuno’s Nanoalloy Face Changes What’s Possible In Driver Design
Mizuno is the first company to put a functional polymer layer in front of a driver face. The implications go well beyond ball speed. For most of the
What could be next for Gakpo?
Following the departure of Mohamed Salah, at least one more attacking signing is expected at Anfield this summer. Liverpool have already signed Victor Munoz from Osasuna for £34.5m and the pursuit of Yan Diomande is heating up. Talented teenager Rio Ngumoha is also set to play a more prominent role, while Florian Wirtz played off the left for Liverpool at times last season and is featuring there for Germany in the World Cup.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
South Dakota mayoral candidates separated by just two votes in shockingly close race, recount expected
The Sioux Falls mayoral runoff contest shockingly resulted in just a two-vote margin separating the candidates out of more than 36,000 ballots cast.
Bo McCalebb Inducted into the Allstate Sugar Bowl New Orleans Sports Hall of Fame
NEW ORLEANS — Former University of New Orleans All-American guard Bo McCalebb reiterated how much he loved his time on the Lakefront as he was inducted into the Allstate Sugar Bowl's New Orleans Sports Hall of Fame on Wednesday night.
FDA-approved drug may finally help immunotherapy defeat rare liver cancer
Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping them in nearby fibrous tissue. An FDA-approved drug called AMD3100 freed those T cells to attack the cancer, significantly improving the effectiveness of immunotherapy in tumor samples.
Fired Navy Admiral Wins Democratic Runoff in South Carolina’s 1st District
Democrats expect Nancy Lacore to run a competitive general election despite the district’s Republican leaning.
Wilson wins GOP nomination for South Carolina governor after Trump hedges his bet on race
South Carolina Attorney General Alan Wilson won a runoff election on Tuesday, swiftly routing the candidate initially endorsed by President Donald Trump to be the Republican nominee for governor.
Populist wins Colombia election, but results are challenged
Conservative political outsider Abelardo de la Espriella held a razor-thin lead after Colombia’s deeply polarized presidential runoff, which is being challenged by the ruling party’s progressive candidate.
Breaking Business News: AbbVie To Acquire Apogee Therapeutics
AbbVie is set to acquire Apogee Therapeutics and its pipeline of multiple clinical-stage candidates in development across inflammatory and immunological diseases, including its lead asset, zumilokibart (APG777), a subcutaneous half-life extended monoclonal antibody targeting interleukin (IL)-13 in atopic dermatitis (AD). Under the terms of the transaction, AbbVie will acquire all outstanding shares of Apogee for $135.11 per share in cash. […]
GOP runoff wins, Tuberville lawsuit reshape Alabama politics
Republican runoff victories, a new Tuberville lawsuit and dismal turnout reveal Alabama’s power struggles heading into the general election season.
“Criminal Approach to Politics”: Trump Ally Abelardo de la Espriella Wins Colombian Presidency
Right-wing Trump ally Abelardo de la Espriella has clinched a narrow victory in Sunday’s runoff presidential election in Colombia, defeating leftist Senator Iván Cepeda, an ally of current President Gustavo Petro. De la Espriella ran a fearmongering, “tough-on-crime” campaign, promising to build mega-prisons inspired by El Salvador’s authoritarian President Nayib Bukele, to bomb “narcoterrorist camps” and to abandon Petro’s peace efforts. His reported victory is also a win for U.S. President Donald Trump, whose administration is waging an intensifying “war on drugs” across Latin America, targeting left-wing leaders like Petro with false allegations and threats of military intervention. “De la Espriella clearly represents a criminal approach to politics: lying, propaganda, coordination and collusion with criminal narcotrafficking, restriction of rights, and money laundering,” says longtime Colombian activist Manuel Rozental. With his victory, says Rozental, “We expect to have military operations and a U.S. intervention within the country. We expect to have human rights abuses. We expect to have militarization. And it’s all for the extraction of resources and the link of drug trafficking to the U.S. government, U.S. interests and global mafia.”
Next Saturday's Politics: Senate, PCS and Huey's Legacy
Explore the Senate runoff election and its ties to Louisiana's political history and Huey's enduring influence on local politics.
AP Decision Notes: What to expect in South Carolina’s state primary runoff
Two of South Carolina’s top officeholders will compete one-on-one for the Republican nomination for governor in a primary runoff election on Tuesday
Small business owner discusses impact of marathon on Duluth
Grandma's Marathon serves as Duluth's unofficial kickoff to summer, drawing runners and supporters who explore the city's shops and North Shore scenery.
Colombia's presidential runoff election will decide how the country continues to tackle drug trafficking
As Colombia's government makes modest gains in disarming guerrillas, voters head to a runoff where the frontrunner vows to abandon peace talks and escalate a hardline war on drug traffickers.
New Liverpool signing dealt World Cup injury setback
Liverpool winger Victor Munoz may have to wait a bit longer to make his FIFA World Cup debut with Spain after suffering an injury setback. The 22-year-old will join the Reds on 1st July after the Mer...
Trump now says either Republican candidate would be a good pick in South Carolina's governor runoff
President Donald Trump has now endorsed both Republican candidates for governor in South Carolina
Trump co-endorses Alan Wilson in SC governor’s race, dealing major blow to Pamela Evette
President Donald Trump is throwing his support behind both Alan Wilson and Pamela Evette in the June 23 runoff for governor. The news represents a major blow to Evette, whose campaign was built on her ties to Trump.
Double endorsement drama: Trump backs second candidate in red state’s GOP gubernatorial runoff
Trump endorses both Wilson and Evette in South Carolina's GOP gubernatorial runoff, hedging his bets ahead of the high-profile Tuesday contest.
Colombia’s Right-Wing Offensive and the Politics of Order
Far-right millionaire Abelardo de la Espriella has a narrow lead ahead of Colombia’s election runoff. Left-wing rival Iván Cepeda speaks of the outgoing government’s achievements, but rising violence has made the campaign especially volatile.
Interventional work increasingly concentrated among smaller subset of radiologists
The proportion of radiologists performing some (>0%) IR-related work declined from 70% in 2008 down to 50% by 2023, according to new research published in JVIR.
Going pro-Trump and endorsing redistricting: 4 takeaways from SC’s 1st District GOP runoff debate
Charleston County Councilwoman Jenny Costa Honeycutt and state Rep. Mark Smith talked affordability, Trump and more in their final debate before Tuesday’s runoff election.
Georgia Republicans choose Collins for Senate and Jackson for governor, a mixed result for Trump
Georgia Republicans delivered a split decision for Donald Trump in Tuesday runoffs, opting for the president’s preferred U.S. Senate candidate but rejecting his choice for governor in favor of a billionaire first-time candidate who spent freely from his personal fortune to win the nomination.
The price tag of overcoming a Trump endorsement, and other takeaways from Tuesday's primaries
Rick Jackson's campaign spent more than $100 million, largely out of his own pocket, to defeat Trump-endorsed Burt Jones in the Republican runoff for Georgia governor.
Trump-endorsed pastor suspends Oklahoma House campaign after texting scandal
Megachurch pastor Jackson Lahmeyer ended his bid after advancing in a runoff. A British tabloid alleged he had an inappropriate relationship with a former staffer.
Pastors for Trump founder withdraws from US House race after texting scandal
Pastors for Trump founder Jackson Lahmeyer on Wednesday announced he was ending his bid for Oklahoma’s 1st Congressional District, one day after he was projected to advance to a runoff for the Republican nomination in the wake of a texting scandal.
Rep. Kevin Hern wins Oklahoma GOP nomination for U.S. Senate, governor's race heads to runoff
The primary had Republicans picking their preferred successor to outgoing Republican Gov. Kevin Stitt and a nominee for the Senate seat once held by Homeland Security Secretary Markwayne Mullin.
Trump-backed candidate wins primary to face Jon Ossoff in Georgia midterms
Republican primary runoff voters chose US representative Mike Collins to face Ossoff in November
World Cup and presidential runoff: How Colombia’s yellow jersey got political
Colombia plays its first game in the World Cup and votes for its next president this week. Its national soccer jersey has ended up stuck in the middle.
Trump wins two, loses one: Georgia billionaire delivers rare blow to endorsement machine
Trump-backed candidates won two of three key GOP runoffs in Georgia and Alabama, but lost the gubernatorial race to billionaire Rick Jackson.
Georgia runoffs 2026: Rick Jackson topples Burt Jones, wins GOP nod for governor
The billionaire healthcare executive won despite President Donald Trump and Gov. Brian Kemp endorsing his opponent.
Georgia gubernatorial candidate Rick Jackson, in his GOP runoff election victory, says his campaign "shattered" the political class
Collins defeats Dooley for GOP U.S. Senate nomination in Georgia
U.S. Rep. Mike Collins will face U.S. Sen. Jon Ossoff in November after winning the Republican runoff in Georgia's Senate contest.
Billionaire Rick Jackson defeats Trump-backed Burt Jones for the GOP nomination in Georgia governor’s race
NBC News projects that Jackson has won the primary runoff and will move on to the general election in the battleground state against Democrat Keisha Lance Bottoms.
Oklahoma begins choosing a new U.S. senator and governor in crowded primary
If no candidate receives at least 50% of the vote, the top two will have a runoff Aug. 25.
5 Things to Know About Derek Dooley, Republican Senate Candidate in Georgia
He is supported by outgoing Gov. Brian Kemp, who has had a tumultuous relationship with President Trump. Mr. Trump backs Mr. Dooley’s runoff opponent.
Trump-backed U.S. Rep. Barry Moore battles ex-Navy SEAL Jared Hudson in GOP Senate runoff in Alabama
The Alabama race will be another test of Trump's endorsement powers, as his picks have largely prevailed in Republican primaries this year.
Live results: Georgia midterm Republican primary runoff
Georgia Republicans will finalize their picks in marquee races for U.S. Senate and governor in a state primary runoff election on Tuesday.
Live results: Alabama midterm primary runoffs
Alabama voters will return to the polls Tuesday to finalize nominees for an open U.S. Senate seat and a handful of other contests in which no candidate received a majority of votes in the May 19 primary.
Georgia Governor Primary Runoff Election 2026 Live Results
See live results from the 2026 Georgia Governor primary runoff election as Republican votes are counted by candidate and county.
Today’s Georgia Runoffs Could Shape Politics for Years
Republicans are selecting a challenger to rising Democratic star Jon Ossoff and a gubernatorial candidate who may oversee voting in 2028.
What to watch in midterm primaries and runoffs in Alabama, Georgia, D.C. and more
President Donald Trump has been at the center of this year's midterm campaigns, and his influence will be tested in different ways Tuesday as four states and the District of Columbia hold primaries.
These 36 Scientists Are Leading the Way to Biomedical Discoveries
On June 16, Pew announced the 2026 class of Pew Scholars Program in the Biomedical Sciences, Pew Latin American Fellows Program in the Biomedical Sciences, and Pew-Stewart Scholars Program for Cancer Research. These researchers will receive multiyear grants and join a community of more than 1,000 scientists who are taking creative approaches to cancer biology, neuroscience, immunology, and more.
Trump-backed US Rep. Barry Moore battles ex-Navy SEAL Jared Hudson in GOP Senate runoff in Alabama
Alabama voters are deciding party nominations for an open U.S. Senate seat
OPCW and UNODA partner to bridge gap between scientists and policymakers
Scientists learn how to apply policy and diplomacy at OPCW-UNODA workshop on chemical and biological disarmament
Two Women, One Mission: Closing the Gap Between Cancer Science and Survival
A journalist-turned-advocate and a physician-scientist unite at the Parker Institute for Cancer Immunotherapy to accelerate cancer vaccines from lab discovery to lifesaving treatment.
Kemp, Trump flex their political muscles days ahead of Georgia’s runoffs
Donald Trump and Brian Kemp broke their silence in two of Georgia's most prominent Republican races.
AP Decision Notes: What to expect in Georgia’s state primary runoff
Georgia Republicans return to the polls Tuesday to pick nominees for U.S. Senate and governor in a state primary runoff election
Study identifies genetic cause for rare skin condition, points to new therapeutic option
The research highlights the value of studying rare genetic diseases to uncover fundamental immunological mechanisms.
In a surprise twist, Brian Kemp endorses Burt Jones for governor
Kemp's endorsement gives Jones a significant boost in the closing days of his bitter runoff against billionaire Rick Jackson
Trump endorses Rep. Mike Collins ahead of GOP Senate runoff in Georgia
President Donald Trump on Sunday waded into the Georgia Republican primary for Senate, endorsing Rep. Mike Collins just days before the congressman faces off against Derek Dooley in a runoff election.
Trump endorses Collins in Georgia Senate runoff. It's his latest 'MAGA' pick in Republican primaries
Days before the U.S. Senate runoff in Georgia, President Donald Trump has made an endorsement
Victor Wembanyama Accused Of 'Classless' Reaction To NBA Finals Loss
Victor Wembanyama and the San Antonio Spurs fell in five on Saturday night. San Antonio blew a double-digit lead to New York, as the Knicks topped the Spurs, 4-1, in the 2026 NBA Finals. Jalen Brunson, Josh Hart, OG Anunoboy, Karl-Anthony Towns and the rest of the Knicks are NBA champions. ...
Trump endorses Mike Collins in runoff, shaking up Georgia’s U.S. Senate race
The decision is a blow to Derek Dooley, the Republican who is backed by Gov. Brian Kemp. Trump's decision will test GOP loyalties in the runoff in June.
President Trump Endorses Mike Collins in Georgia Senate Runoff
Mr. Trump backed Mr. Collins over Derek Dooley, a former football coach who is supported by Gov. Brian Kemp, a Republican whose relationship with the president is strained.
Dooley campaigns with Kemp in Middle Georgia as lawmakers allege 'pay-to-play politics'
Derek Dooley is making some of his final pitches to voters in Middle Georgia as the U.S. Senate runoff inches closer to Election Day, and his campaign faces...
Will Trump Spend His $350 Million War Chest to Win Texas? Republicans Are Worried
By Nolan D. McCaskill WASHINGTON, June 13 (Reuters) - Republicans want President Donald Trump to put his money where his mouth is: behind his scandal-plagued ally, Texas Attorney General Ken Paxton. Paxton ousted four-term Senator John Cornyn in a primary runoff last month on the heels of Trump's ...
Runoffs provide Trump’s next big GOP tests: From the Politics Desk
Plus, deal or no deal with Iran?
Frisco Mayor’s Race Tests Anti-Muslim Politics in Texas
A runoff in the Dallas suburb of Frisco is testing whether anti-Muslim rhetoric, prominent in G.O.P. primaries this year, can win over a broader set of voters.
First attacks fly in South Carolina GOP governor's runoff. What’s fact and what’s fiction?
Pamela Evette has come out of the gate hard in the opening days of the 2026 runoff election against Alan Wilson, attacking him over his support for Democrat James E. Smith for a judicial seat in 2024.
Mateen Appointed Director of New Center for Global Neurology
Farrah Mateen, MD, PhD, chief of the Division of Multiple Sclerosis & Neuroimmunology and the Dr. Charles L. Mix Research Professor of Neurology, has been named director of the Center for Global Neurology, a center of the Robert J. Havey, MD Institute for Global Health (IGH).
The facts didn’t fit Trump’s California conspiracy theory. So he adjusted the conspiracy theory
If you’re pushing the baseless conspiracy theory that the results of last week’s California primary elections were rigged against Republicans like gubernatorial candidate Steve Hilton, it would seem highly inconvenient that Hilton has succeeded in qualifying for the November runoffs.
After divisive U.S. Senate runoff, Texas Republicans seek unity at state convention in Houston
Now that the party's nominees are set for the general election, Texas Republicans are shifting their focus to defeating Democrats in November. The 2026 Republican Party of Texas State Convention runs through Saturday.
LatAm in Focus: De la Espriella, Cepeda, and Colombia’s Political Divide
Political scientist Dr. Sanda Borda examines the figures and forces shaping the presidential race ahead of the June 21 runoff.
Mariners News: Matt Brash, Max Scherzer, and OG Anunoby
It’s Thursday, and if it’s Thursday, it’s not Meet the Links.
OG Anunoby saves Knicks with game-winning tip-in, huge block in historic Finals comeback: 'It feels cool'
NBA Finals: A Wu-Tang prayer, OG Anunoby, Jose Alvarado and the greatest comeback in NBA history
'Resilient' Knicks on brink of NBA title after record rally
OG Anunoby's game-clinching tip-in to put New York on the brink of an NBA title will go down as one of the greatest plays in Knicks history, coach Mike Brown said."The tip, how he had to control it and tip it in -- that has to be the most iconic shot in the history of New York basketball."
US business group says some critical minerals are 'nearly unobtainable' from China
U.S. access to critical minerals from China remains difficult due to export controls and licensing delays, a U.S. business lobby said on Wednesday, with Beijing's restrictions driving three-quarters of impacted companies to search for new supplies.
Business Restructuring Review Vol. 25 No. 3 May-June 2026
In This Issue Texas Bankruptcy Court Adopts Barnet Rule Requiring Foreign Debtor to Have U.S. Assets to Be Eligible for Chapter 15 Relief In In re Siu-Fung Ceramics Holdings Limited, No. 24-33299, 2026 WL 382424 (Bankr. S.D. Tex. Feb. 10, 2026), the court denied petitions for chapter 15 recognition of Hong Kong bankruptcy and liquidation proceedings commenced on behalf of an individual debtor and a group of companies that he owned or controlled. According to the court: (i) the corporate debtors' Hong Kong liquidation proceeding was not eligible for chapter 15 recognition because the attorney retainer upon which such relief was based was not funded until nine months after the chapter 15 petition date; and (ii) the individual debtor's Hong Kong bankruptcy case could not be recognized because the debtor's "center of main interests" on the chapter 15 petition date was not in Hong Kong, and he did not even maintain an "establishment" there. [read more …] Southern District of Texas Clarifies Post-Purdue Course for Consensual Third-Party Releases and Gatekeeping Provisions In In re Container Store Group, Inc., 676 B.R. 356 (S.D. Tex. 2026), appeal filed, No. 26-20166 (5th Cir. Apr. 14, 2026), cross appeal filed, No. 26-20166 (5th Cir. Apr. 24, 2026), the U.S. District Court for the Southern District of Texas addressed consensual third-party releases and gatekeeping provisions in the aftermath of the U.S. Supreme Court's ruling in Harrington v. Purdue Pharma L.P., 603 U.S. 204 (2024). Consistent with existing Fifth Circuit precedent, the court confirmed that, in appropriate circumstances, consent for third-party releases may be obtained through a creditor's failure to opt out of granting that consent. But, the court ruled, consent through an opt-out mechanism essentially can never be inferred for creditor classes that stand to receive no recovery under a chapter 11 plan and that are deemed to reject the plan by operation of applicable bankruptcy law. Instead, those classes must affirmatively opt in to any release. The court also narrowed and remanded the bankruptcy court's acceptance of a broad gatekeeping provision, ruling that such provisions must correspond to the restrictions established by Fifth Circuit precedent. [read more …] Delaware Bankruptcy Court: Initial Transferee Need Not Be Defendant in Fraudulent Transfer Avoidance and Recovery Litigation The Bankruptcy Code gives a bankruptcy trustee the power to avoid asset transfers that are either made with the intent to defraud creditors or that are "constructively" fraudulent because an insolvent debtor did not receive adequate value in exchange. The Bankruptcy Code also permits recovery of an avoided transfer from not only the initial recipient, but also from subsequent transferees. Courts disagree over whether a transfer must actually be avoided before the trustee can seek recovery from a subsequent transferee and whether the initial transferee must also be a defendant in the recovery litigation against a subsequent transferee. The U.S. Bankruptcy Court for the District of Delaware weighed in on this debate in Phillips v. SS Associates LLC (In re ONH AFC CS Investors, LLC), No. 23-10931 (CTG), 2026 WL 312892 (Bankr. D. Del. Feb. 4, 2026). The court adopted the majority view, ruling that the initial transferee need not be a defendant in avoidance and recovery litigation against a subsequent transferee, but that the trustee must establish the elements necessary to avoid the initial transfer as part of the recovery litigation. [read more …] New York Bankruptcy Court Weighs In on Adequate Assurance of Future Performance under Assigned Leases and Chapter 11 Plan Exculpation Provisions In order to assume and assign an executory contract or unexpired lease, a bankruptcy trustee must cure most defaults under the agreement and provide "adequate assurance" of the assignee's future performance. However, the Bankruptcy Code provides no guidance as to the meaning of "adequate assurance" other than with respect to shopping center leases. In In re Broadway Realty I Co. LLC, No. 25-11050, 2026 WL 147505 (Bankr. S.D.N.Y. Jan. 19, 2026), the U.S. Bankruptcy Court for the Southern District of New York examined this issue in connection with a proposed assignment of thousands of residential leases as part of a free-and-clear sale of debtors' properties. The court held that "adequate assurance" does not mean a guarantee of the assignee's future performance, but merely demonstration that the assignee has the ability to satisfy the underlying obligations. The bankruptcy court also ruled that an exculpation provision in the debtors' chapter 11 plan exonerating non-estate fiduciaries from liability for actions taken in connection with the chapter 11 case was unobjectionable, provided it was limited in scope to postpetition conduct and actions taken in connection with implementation of the plan after its effective date. [read more …] Newsworthy Corinne Ball (New York) (Hall of Fame), Bruce Bennett (Los Angeles), Carl E. Black (Cleveland), Jeffrey B. Ellman (Atlanta), Brad B. Erens (Chicago), Gregory M. Gordon (Dallas), Heather Lennox (Cleveland/New York), Joshua M. Mester (Los Angeles), and Kevyn D. Orr (Washington) were included in the 2026 edition of Lawdragon 500 Leading Bankruptcy and Restructuring Lawyers. The Daily Business Review selected Isel M. Perez (Miami) as an "On the Rise" winner for the Florida Legal Awards. The Florida Legal Awards annually recognize those who have made significant contributions to the legal industry in Florida. Dan T. Moss (Washington/New York) was inducted as a Fellow in the 37th Class of the American College of Bankruptcy at its Annual Meeting in March 2026 in San Antonio, Texas. Christine Borries (Munich) was ranked in the practice area Restructuring/Insolvency in the 2026 edition of Chambers Germany. The 2027 edition of The Best Lawyers in Singapore™ recognized Sushma Jobanputra (Singapore) in the practice area Insolvency & Reorganization. The restructuring transaction involving Eissmann Automotive North America, Inc. received the "2025 Turnaround of the Year (Large Company)" at the Turnaround Management Association (Detroit) Annual Awards Reception. T. Daniel Reynolds (Cleveland) and Nick Buchta (Cleveland) represented subsidiaries of Eissmann Group Automotive in connection with the parent company's German insolvency proceedings. Roger Dobson (Sydney) is among 40 Jones Day lawyers recognized by The Best Lawyers in Australia 2027 for his contributions in Banking and Finance Law; Distressed Investing & Debt Trading; Insolvency and Reorganization Law; Litigation. An article written by Corinne Ball (New York) titled "Ard Finance—A Global Enterprise Combining an LME With a Foreign Insolvency Proceeding and Chapter 15" was published in the April 21, 2026, edition of the New York Law Journal. An article written by Alex Sapp (New York) titled "Recent Developments in Section 510—Subordination" was published in the 2025 edition of the Norton Annual Survey on Bankruptcy Law. An article written by Brad B. Erens (Chicago) titled "New York Bankruptcy Court Approves Insider DIP Litigation Financing" was published on April 6, 2026, by Lexis Practical Guidance. An article written by Corinne Ball (New York), Dan T. Moss (Washington/New York), David S. Torborg (Washington), and Isel M. Perez (Miami) titled "New York District Court Affirms Narrow Scope of 'Public Policy Exception' in Chapter 15 Cases" was published on April 6, 2026, by Lexis Practical Guidance. An article written by Jeffrey B. Ellman (Atlanta) titled "Statutory Cap on Lease Rejection Damage Claims in Bankruptcy Applies to Solvent Debtors" was published on April 6, 2026, by Lexis Practical Guidance. An article written by Trisha L. Mowbray (Real Estate; Chicago) and Ryan Sims (Washington) titled "Chapter 11 Plan that Abridged Non-Debtor Lessee's Rights to Remain in Possession After Rejection Unconfirmable as Having Been Proposed in Bad Faith" was published on April 6, 2026, by Lexis Practical Guidance. Lawyer Spotlight: Ben Rosenblum Ben Rosenblum, a partner in the New York Office, represents debtors, creditors, and other parties in out-of-court restructurings and court-supervised proceedings, including chapter 11 cases, municipal bankruptcies, international insolvency matters, and stockbroker liquidations. His experience spans industries such as manufacturing, shipping, mining, aviation, energy, real estate, and telecommunications. Ben's notable debtor representations include Peabody Energy, the City of Detroit, Chrysler LLC, Spansion Japan, and Dana Corporation. Significant creditor representations include General Maritime Corporation, Calpine Corporation, American Home Mortgage, and Murray Energy. He currently represents creditors in Puerto Rico's restructuring. He also has extensive experience advising financial institutions on bankruptcy law as applied to derivatives.
New OMB rule could break science in the United States
The drug that saved your mother. The treatment your doctor recommended. The clinical trial that bought someone you love more time. None of it was inevitable. It required a system built to operate outside politics and sustained over decades, because science doesn’t operate on the timeline of a politician. That system is now under direct threat. The Office of Management and Budget (OMB) has proposed a new rule to regulate all federal grants, not just science, but housing, education, defense, NASA and everything in between, that would fundamentally change how research is conducted in the United States. There have been a lot of fires in the past 16 months, and if everything is an emergency, nothing is an emergency. But this is a very big deal. These rules would strip away the independence that has kept science from becoming a political tool. The good news is there’s still something we can all do. How the grant system was designed to work When I was a new faculty member, I was full of millions of ideas, so I sat down and wrote an NIH proposal. I worked on it for months and thought it was so good. Then I sent it to my mentor. It came back covered in comments. Places where my reasoning wasn’t as airtight as I’d thought, methods that could be stronger, gaps in my thinking that I had been too close to the work to see. It stung, as honest feedback always does, but peer review almost always makes the work better. In fact, it’s the backbone of how American science has functioned for generations. At NIH, submitted proposals go to a panel of scientists who have experience in the field. These are the people who can read research methods and spot their weaknesses, who understand when an experiment is designed well and when it isn’t. Applications are scored rigorously, and often only the top 3-20% of proposals receive funding. The people making funding decisions are required to justify them based on these reviews. To be clear: this is not a perfect system, and good science still goes unfunded more often than any of us would like due to limited resources. There is also criticism that peer review may undervalue bold ideas that are risky but could have high payoffs. But the peer review system is nonetheless a meaningful part of the grant selection process. While thoughtful and careful changes could improve the system, the changes being proposed by OMB will not make things better. The rule that could change everything Through this OMB proposal, the system that helps decide what gets funded is being dismantled. There are many troubling elements buried in this proposal, but three provisions stand out in particular. Each would be damaging alone. Together, they would change what kind of science gets done in America, and who it serves. 1. Political appointees would decide which science gets funded, and peer review would be explicitly sidelined or ignored. The guidelines your doctor follows, the standards that determine what’s in your air and water, the drugs that get approved for your family: all of it starts with a funding decision. Right now, that decision is made by scientists who can evaluate whether the work is actually sound and whether it could move the needle forward. Under this proposal, funding decisions could be made by political appointees. The careful, expertise-driven review process that shapes grant funding would be effectively sidelined. That means that a poorly designed study could get funded simply because someone in a political office liked the sound of it, while rigorous, important work doesn’t get funded because it no longer aligns with the administration’s priorities. In other words, critical work that benefits all of us could now be missed just because it has become politically inconvenient. 2. Grants could be canceled at any point, without warning, in the middle of ongoing work. Say your tax dollars have been paying for a cancer study for two years. The grant was awarded for five years, so the team is mid-experiment. There are three additional years’ worth of answers that could change how the disease is treated for hundreds of thousands of people. With this new rule, the federal government could cancel the remaining funding tomorrow, walk away from the commitment it made with your money, and have no legal obligation to finish what it started. This is a huge waste of money. There are rarely other sources of funding for this work, which means the team, the graduate students, postdocs, and research staff who have dedicated years of their careers to this project could lose their jobs. Patients who have contributed their time to studies may not see it turn into useful learnings for others. Every hour of work already completed could result in nothing useful. Science can take decades to get to tangible outcomes. It needs a stable funding system to flourish. 3. Researchers would have a harder time communicating their findings without pre-approval from the federal government. There is a saying from Sir Mark Walport: “Science isn’t finished until it’s communicated.” Science is no use to anyone if it is kept locked away in the labs that produced the data. The proposed rule could make communicating research findings harder in a number of ways: Make it harder for scientists to widely share their findings in scientific journals. Publication costs, including journal fees that allow for broad public access, could not be paid for by federal funds which is often how scientists pay these costs. Restrict researchers from engaging publicly about how their findings should inform policy or public health guidelines. This would restrict scientists from doing the work that transforms years of lab work into decisions that actually affect people’s lives. Make it harder for scientists to attend conferences. Conferences would now need to be approved by the federal agency at the time of grant award. This disadvantages conferences or publications that are not politically aligned. Conferences are a key way in which scientists learn about work happening in their field so they can collaborate and build on each other’s findings. What good is science with a muzzle? The long-term impact These changes could (and hopefully would) be reversed under the next administration. But by then, damage has been done. Once projects are halted or denied funding by political appointees, people leave their science careers for other paths or even leave the country to do their amazing science elsewhere. You cannot pause a scientific study the way you pause a subscription you decided isn’t useful anymore. You cannot freeze a research team that depends on salaries to feed their families, causing a scramble for replacement funding that, in most cases, simply does not exist. When the money stops, everything stops, and all the work in progress and its potential are lost. Despite all of the language about reducing waste, fraud, and abuse, this new proposed rule increases the administrative burden tremendously. Every researcher watching this unfold will make a rational decision: don’t start anything that will take a decade to finish. This includes not building a team around funding that could vanish, or asking the big questions that need patience and stability to answer. The most consequential science, the kind that produces the treatments and the breakthroughs that reach your doctor’s office twenty years from now, is exactly the science that would be abandoned first. This is still a proposal, so we can all do something Some worry this rule is already a done deal. But by law, OMB is required to open a public comment period. Those comments matter because they inform members of Congress, they can be used in litigation, and they create a public record. So here’s what you can do: Submit a public comment. The public comment period on this proposed change is open until July 13. Anyone can submit a comment, and OMB is required to respond to substantial ones. Each comment must be different to count as distinct; identical comments will be counted only once. Comment as an individual, not on behalf of your organization. Here’s a full resource to help you, with useful examples, but in general: Share a story about how science or federal funding has benefitted you or is involved in your work. Are you or someone you loved a cancer survivor? Do you know someone with Alzheimer’s? Have you received NIH/NSF or other federal funding? All of these can be stories you use to highlight why you care. Explain why you’re worried about these proposed changes. You can use the wording found here or in other resources to help you. Ask them to withdraw this proposed rule. Contact your elected representatives. Congress allocates money to federal agencies to spend, and it has oversight of how that process works. You can let your representatives know this proposed change concerns you and ask them to intervene. There are levers they can push that can help at this moment. Let others know why federal funding matters. This isn’t just about science, but ALL federal grants, including for education systems, defense projects, and more. The process, including the importance of federal funding, is invisible to many. We can all make it more visible by sharing how science benefits us and why we value it. You can also share this article, or any of the resources linked here, to help spread awareness! Bottom line We are quickly losing ground in scientific research in the U.S. More changes, like the proposed rule by OMB, would decimate our ability to conduct research here, leaving us all worse off: fewer treatments for pancreatic cancer, less research on pollution impacts, fewer answers for patients with rare disease, and more unaddressed health needs. The impact will be very real for all of us, regardless of where we stand politically. Using our voices for science is more important than ever. Love, LM Big thanks to Dr. Megan Ranney for reading this over and providing brilliant insights, as always. Dr. Liz Marnik, PhD, is Executive Director of The Evidence Collective at YLE and a science communicator and immunologist working at the intersection of public trust, science, and public health. You can find her on Substack, LinkedIn, Instagram and Threads. Your Local Epidemiologist (YLE) comprises a team of experts, ranging from physicians to immunologists to epidemiologists to nutritionists, working together with one goal: to “Translate” ever-evolving public health science so that people are well-equipped to make evidence-based decisions. The YLE suite of newsletters reaches over 475,000 people across more than 132 countries. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
Once a rising star, Nancy Mace suffers resounding defeat in governor’s race
The South Carolina congresswoman finished fifth in the state’s GOP gubernatorial primary, according to unofficial returns, solidly losing even her own home county and district.
2nd District, gubernatorial races to go to ranked-choice runoff
Republican Bobby Charles declared himself the first-round leader in the GOP gubernatorial race.
Pamela Evett, Alan Wilson advance to runoff in crowded South Carolina primary, CBS News projects
Evette and Wilson Advance to Runoff in South Carolina Republican Primary for Governor
Lt. Gov. Pamela Evette had gotten an endorsement from President Trump, but it was not enough to help her clinch a victory outright. She now faces Alan Wilson, the state attorney general, in a runoff on June 23.
Navy Admiral Fired by Hegseth Advances to Runoff to Replace Mace
Nancy Lacore would face a tough fall election in a district drawn in 2021 to be more Republican. She is seeking to replace Representative Nancy Mace, who ran unsuccessfully for governor instead of running for re-election.
Progressive Nithya Raman advances to November runoff against Los Angeles Mayor Karen Bass
The election will test whether voters in the heavily Democratic city want to move further to the political left to address long-running problems of homelessness, buckled streets and sidewalks and climbing rent and home prices.
Attorney General Tong Sues North Haven Business Owner
Attorney General William Tong today, on behalf of the Department of Energy and Environmental Protection (DEEP), sued Bruno F. Suraci, Jr., his North Haven metal finishing business NikLyn, and related companies for serial violations of Connecticut’s air pollution control regulations.
Nithya Raman ‘incredibly honoured’ to advance to LA mayor runoff after seeing off Republican
Left-wing candidate vows ‘fight for a healthier, safer and more joyful Los Angeles’ after edging out Spencer Pratt
Liberal council member advances to runoff with Bass in Los Angeles mayor’s race
Nithya Raman will head to a runoff with Mayor Karen Bass (D), edging out Republican reality TV star Spencer Pratt.
Nithya Raman advances over Spencer Pratt to face L.A. Mayor Karen Bass in a runoff
NBC News projects Bass, the Democratic incumbent, and Raman, a City Council member, will face off in November after receiving the most votes in the all-party first-round election.
Nithya Raman, Spencer Pratt locked in tight race for LA mayor runoff
The race was still too early to call on Sunday as the vote tally showed Raman moving into second place behind the incumbent Bass
The Brayan Bello situation is existential
I’m officially giving up on trying to understand the 2026 version of Brayan Bello. It’s Monday Morning Brushback time, y’all, I guess? I dunno, this is another unorthodox MMBB, but this is what I feel in my heart. This is not the first time this season that I’ve gone into the weekend looking to write […]
Nithya Raman and Spencer Pratt locked in tight race to make runoff for Los Angeles mayor
Days after California’s primary, Nithya Raman and Spencer Pratt are still waiting to see who makes the November runoff for Los Angeles mayor against incumbent Karen Bass | News-Talk 1380 WAOK
Nithya Raman and Spencer Pratt locked in tight race to make runoff for Los Angeles mayor
Days after California’s primary, Nithya Raman and Spencer Pratt are still waiting to see who makes the November runoff for Los Angeles mayor against incumbent Karen Bass.
Nithya Raman leaps past Spencer Pratt in tight, unresolved race to make L.A. mayoral runoff
NBC News has not yet projected who will join incumbent Mayor Karen Bass in the November runoff election.
Trump Looms Over Pivotal Republican Senate Runoff in Georgia
The president has not yet endorsed Representative Mike Collins or Derek Dooley, a former football coach, in the race to challenge the Democratic senator, Jon Ossoff.
Bruno Fernandes scores winner as Portugal beat Chile
Bruno Fernandes scored the decisive goal as Portugal beat Chile 2-1 in a World Cup warm-up fixture.The Manchester United continued his outstanding club form for the national team, sweeping in the seco...